Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Electromyographic | Research article

Cystinosis beyond kidneys: gastrointestinal system and muscle involvement

Authors: Rezan Topaloglu, Ayşe Gültekingil, Bora Gülhan, Fatih Ozaltin, Hülya Demir, Türkmen Çiftci, Numan Demir, Çağrı Mesut Temucin, Aysel Yuce, Okhan Akhan

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Cystinosis is a multisystemic disease resulting from cystine accumulation primarily in kidney and many other tissues. We intended to study the evolution of less commonly seen extrarenal complications of cystinosis in a group of patients who have periods without cysteamine treatment.

Methods

Gastrointestinal and muscular complications of cystinosis were studied in a group of 21 patients.

Results

Twenty one patients were included in the study. Among them, 14 were homozygous and 3 were compound heterozygous for CTNS mutations. The median age of diagnosis was 15 months (range; 5 months-14 years) and the mean age at last visit was 11.3 ± 6.5 years. Nine patients (42%) had end stage renal disease at a mean age of 10.6 years (6.5–17 years). Abdominal ultrasonography and portal vein doppler ultrasonography were performed in19 patients, 14 of them (74%) had hepatomegaly, 10 patients (53%) had granular pattern or heterogeneity of liver. Only one patient had high transaminase levels and liver biopsy showed cystine crystals in the liver. Eleven patients (58%) had borderline or increased portal vein minimum and maximum flow velocities. One patient had CK level of 9024 U/L and electromyographic study showed active myopathic involvement. Two patients were found to have gastroesaphageal reflux only and 4 patients were found to have esophageal remnants in addition to reflux.

Conclusions

In addition to renal functions, extrarenal organs may be affected from cystine accumulation even in childhood, especially in patients who are incompliant to treatment, resulting in complications such as swallowing difficulty, hepatomegaly and portal hypertension.
Literature
15.
go back to reference Klenn PJ, Rubin R. Hepatic fibrosis associated with hereditary cystinosis: a novel form of noncirrhotic portal hypertension. Mod Pathol. 1994;7:879–82.PubMed Klenn PJ, Rubin R. Hepatic fibrosis associated with hereditary cystinosis: a novel form of noncirrhotic portal hypertension. Mod Pathol. 1994;7:879–82.PubMed
16.
go back to reference Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR. Feeding problems in cystinosis. Pediatr Nephrol. 1998;12:365–70.CrossRef Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR. Feeding problems in cystinosis. Pediatr Nephrol. 1998;12:365–70.CrossRef
19.
go back to reference Vester U, Schubert M, Offner G, Brodehl J. Distal myopathy in nephropathic cystinosis. Pediatr Nephrol. 2000;14:36–8.CrossRef Vester U, Schubert M, Offner G, Brodehl J. Distal myopathy in nephropathic cystinosis. Pediatr Nephrol. 2000;14:36–8.CrossRef
22.
go back to reference Ulusoy M, Tunçbilek E. Türkiye'de Akraba Evlilikleri ve Çocuk ölümlerine Etkisi. Turkish J Popul Stud 1979–1988; Cumulative lndex to Volumes 1–10. Ulusoy M, Tunçbilek E. Türkiye'de Akraba Evlilikleri ve Çocuk ölümlerine Etkisi. Turkish J Popul Stud 1979–1988; Cumulative lndex to Volumes 1–10.
30.
go back to reference Sadjadi R, Sullivan S, Grant N, Thomas SE, Doyle M, Hammond C, et al. Clinical myopathy in patients with Nephropathic Cystinosis. Muscle Nerve. 2020;61:74–80.CrossRef Sadjadi R, Sullivan S, Grant N, Thomas SE, Doyle M, Hammond C, et al. Clinical myopathy in patients with Nephropathic Cystinosis. Muscle Nerve. 2020;61:74–80.CrossRef
Metadata
Title
Cystinosis beyond kidneys: gastrointestinal system and muscle involvement
Authors
Rezan Topaloglu
Ayşe Gültekingil
Bora Gülhan
Fatih Ozaltin
Hülya Demir
Türkmen Çiftci
Numan Demir
Çağrı Mesut Temucin
Aysel Yuce
Okhan Akhan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01385-x

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine